| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |